Betanoid Tablets
PDF Leaflet Revision Date: 26 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of inflammatory conditions where a steroid is indicated.
Dosage (summary)
0.5 mg to 5 mg daily in divided doses; can be given once daily in the morning.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
- Diabetes mellitus
- Post-menopausal females
Pregnancy & Breastfeeding
Safety during pregnancy and lactation not established; may affect fetal development.
Key Drug Interactions
- Anticholinesterases in myasthenia gravis
- NSAIDs may increase gastrointestinal bleeding
- CYP3A inhibitors may increase systemic side effects
Contraindications
- Hypersensitivity to betamethasone
- Systemic fungal infections
- Peptic ulceration
- Active tuberculosis
- Live vaccines
Common side effects
- Increased susceptibility to infections
- Cushing's syndrome
- Hyperglycemia
- Osteoporosis
- Psychiatric disturbances
Counselling Points
- Take in the morning to minimize side effects
- Avoid exposure to infections like chickenpox
- Monitor for psychological symptoms
Serious warnings
- Risk of myocardial rupture post-MI
- Adrenal suppression with prolonged use
- Potential for severe psychiatric reactions
Important Disclaimer
The Betanoid Tablets professional information leaflet below is the property of Pharmacare Limited and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
